Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.

Maria Torrente, Pedro A Sousa,Fabio Franco, Gracinda Guerreiro,Alexandre Sousa,Consuelo Parejo,Joao Pimentao,Mariano Provencio

Clinical medicine (London, England)（2022）

引用 0|浏览3

暂无评分

摘要

Lung cancer represents a significant global health problem, accounting for more than 1.7 million deaths worldwide in 2021.[1][1] Despite advances in cancer treatment over the last decade, the 5-year survival rate is still around 50% for surgically resected non-small-cell lung cancer (NSCLC). Even

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要